<DOC>
	<DOC>NCT00263549</DOC>
	<brief_summary>The trial is performed to assess efficacy and safety of Novo-Helisen Depot in allergic Rhinoconjunctivitis</brief_summary>
	<brief_title>Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description />
	<criteria>Positive skin prick test to house dust mite, Positive RAST test to house dust mite, Positive provocation test result to house dust mite, Serious chronic diseases, Other perennial allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>House dust mite,</keyword>
	<keyword>Allergy</keyword>
</DOC>